We analyzed CTCAE adverse events of sequential Carbon Ion radiotherapy (CIRT) and immune checkpoint inhibitors (ICIs) in advanced melanoma patients. The frequencies of early and late adverse events (AEs) were 100% and 82% of patients, respectively. The frequency of G3+ AEs was in line with the literature.

Toxicity of carbon ion radiotherapy and immune checkpoint inhibitors in advanced melanoma / S. Cavalieri, S. Ronchi, A. Barcellini, M. Bonora, B. Vischioni, V. Vitolo, R. Villa, M. Del Vecchio, L. Licitra, E. Orlandi. - In: RADIOTHERAPY AND ONCOLOGY. - ISSN 0167-8140. - 164(2021 Nov), pp. 1-5. [10.1016/j.radonc.2021.08.021]

Toxicity of carbon ion radiotherapy and immune checkpoint inhibitors in advanced melanoma

S. Cavalieri;L. Licitra;
2021

Abstract

We analyzed CTCAE adverse events of sequential Carbon Ion radiotherapy (CIRT) and immune checkpoint inhibitors (ICIs) in advanced melanoma patients. The frequencies of early and late adverse events (AEs) were 100% and 82% of patients, respectively. The frequency of G3+ AEs was in line with the literature.
adverse events; carbon ion radiotherapy; carbon ion radiotherapy and immunotherapy combination; Immune checkpoint inhibitors; mucosal melanoma
Settore MED/06 - Oncologia Medica
nov-2021
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0167814021067153-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 233.52 kB
Formato Adobe PDF
233.52 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/873676
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 9
social impact